Cytidine
|
|
| Names
|
| IUPAC name
Cytidine
|
Systematic IUPAC name
4-Amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one
|
| Other names
4-Amino-1-β-D-ribofuranosyl-2(1H)-pyrimidinone[1] 4-Amino-1-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
|
| Identifiers
|
CAS Number
|
- 65-46-3
Y
|
3D model (JSmol)
|
|
| ChEBI
|
- CHEBI:17562
Y
|
| ChEMBL
|
- ChEMBL95606
Y
|
| ChemSpider
|
- 5940
Y
|
IUPHAR/BPS
|
|
| KEGG
|
- D07769
Y
|
| MeSH
|
Cytidine
|
|
|
|
| UNII
|
- 5CSZ8459RP
Y
|
InChI
InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1 YKey: UHDGCWIWMRVCDJ-XVFCMESISA-N YInChI=1/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m1/s1 Key: UHDGCWIWMRVCDJ-XVFCMESIBD
|
SMILES
O=C1/N=C(/N)\C=C/N1[C@@H]2O[C@@H]([C@@H](O)[C@H]2O)CO
|
| Properties
|
Chemical formula
|
C9H13N3O5
|
| Molar mass
|
243.217
|
| Appearance
|
white, crystalline powder[2]
|
| Melting point
|
230 °C (decomposes)[1]
|
Magnetic susceptibility (χ)
|
-123.7·10−6 cm3/mol
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Y verify (what is Y N ?)
|
| Infobox references
|
|
|
|
Tracking categories (test):
Cytidine (symbol C or Cyd) is a nucleoside molecule that is formed when cytosine is attached to a ribose ring (also known as a ribofuranose) via a β-N1-glycosidic bond. Cytidine is a component of RNA. It is a white water-soluble solid.[2] which is only slightly soluble in ethanol.[1]
Dietary sources
Dietary sources of cytidine include foods with high RNA (ribonucleic acid) content,[3] such as organ meats, brewer's yeast, as well as pyrimidine-rich foods such as beer. During digestion, RNA-rich foods are broken-down into ribosyl pyrimidines (cytidine and uridine), which are absorbed intact.[3] In humans, dietary cytidine is converted into uridine,[4] which is probably the compound behind cytidine's metabolic effects.
Cytidine analogues
A variety of cytidine analogues are known, some with potentially useful pharmacology. For example, KP-1461 is an anti-HIV agent that works as a viral mutagen,[5] and zebularine exists in E. coli and is being examined for chemotherapy. Low doses of azacitidine and its analog decitabine have shown results against cancer through epigenetic demethylation.[6]
Biological actions
In addition to its role as a pyrimidine component of RNA, cytidine has been found to control neuronal-glial glutamate cycling, with supplementation decreasing midfrontal/cerebral glutamate/glutamine levels.[7] As such, cytidine has generated interest as a potential glutamatergic antidepressant drug.[7]
Related compounds
- Deoxycytidine is cytosine attached to a deoxyribose.
Properties
References
- ↑ 1.0 1.1 1.2 William M. Haynes (2016). CRC Handbook of Chemistry and Physics (97th ed.). Boca Raton: CRC Press. pp. 3–140. ISBN 978-1-4987-5429-3. https://books.google.com/books?id=VVezDAAAQBAJ.
- ↑ 2.0 2.1 Robert A. Lewis, Michael D. Larrañaga, Richard J. Lewis Sr. (2016). Hawley's Condensed Chemical Dictionary (16th ed.). Hoboken, New Jersey: John Wiley & Sons, Inc.. p. 688. ISBN 978-1-118-13515-0.
- ↑ 3.0 3.1 Jonas DA; Elmadfa I; Engel KH et al. (2001). "Safety considerations of DNA in food". Ann Nutr Metab 45 (6): 235–54. doi:10.1159/000046734. PMID 11786646. http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=anm45235.
- ↑ "Effect of oral CDP-choline on plasma choline and uridine levels in humans". Biochem. Pharmacol. 60 (7): 989–92. Oct 2000. doi:10.1016/S0006-2952(00)00436-6. PMID 10974208.
- ↑ John S. James. "New Kind of Antiretroviral, KP-1461". AIDS Treatment News. http://www.aidsnews.org/2007/10/kp-1461.html.
- ↑ "Scientists reprogram cancer cells with low doses of epigenetic drugs". Medical XPress. March 22, 2012. http://medicalxpress.com/news/2012-03-scientists-reprogram-cancer-cells-doses.html.
- ↑ 7.0 7.1 Machado-Vieira, Rodrigo; Salvadore, Giacomo; DiazGranados, Nancy; Ibrahim, Lobna; Latov, David; Wheeler-Castillo, Cristina; Baumann, Jacqueline; Henter, Ioline D. et al. (2010). "New Therapeutic Targets for Mood Disorders". The Scientific World Journal 10: 713–726. doi:10.1100/tsw.2010.65. ISSN 1537-744X. PMID 20419280.
External links
Nucleic acid constituents |
|---|
| Nucleobase |
- Purine
- Adenine
- Guanine
- Hypoxanthine
- Xanthine
- Purine analogue
- Pyrimidine
- Uracil
- Thymine
- Cytosine
- Pyrimidine analogue
- Unnatural base pair (UBP)
|
|---|
| Nucleoside | | Ribonucleoside |
- Adenosine
- Guanosine
- 5-Methyluridine
- Uridine
- 5-Methylcytidine
- Cytidine
- Pseudouridine
- Inosine
- N6-Methyladenosine
- Xanthosine
- Wybutosine
|
|---|
| Deoxyribonucleoside |
- Deoxyadenosine
- Deoxyguanosine
- Thymidine
- Deoxyuridine
- Deoxycytidine
- Deoxyinosine
- Deoxyxanthosine
|
|---|
|
|---|
Nucleotide (Nucleoside monophosphate) | | Ribonucleotide |
- AMP
- GMP
- m5UMP
- UMP
- CMP
- IMP
- XMP
|
|---|
| Deoxyribonucleotide |
- dAMP
- dGMP
- dTMP
- dUMP
- dCMP
- dIMP
- dXMP
|
|---|
| Cyclic nucleotide |
- cAMP
- cGMP
- c-di-GMP
- c-di-AMP
- cADPR
|
|---|
|
|---|
| Nucleoside diphosphate | |
|---|
| Nucleoside triphosphate |
- ATP
- GTP
- m5UTP
- UTP
- CTP
- ITP
- XTP
|
- dATP
- dGTP
- dTTP
- dUTP
- dCTP
- dITP
- dXTP
|
|
|---|
Glutamate receptor modulators |
|---|
Metabotropic glutamate receptor modulators |
|---|
| Group I | | mGluR1 |
- Agonists: ACPD
- DHPG
- Glutamate
- Ibotenic acid
- Quisqualic acid
- Ro01-6128
- Ro67-4853
- Ro67-7476
- VU-71
- Theanine
- Antagonists: BAY 36-7620
- CPCCOEt
- Cyclothiazide
- LY-367,385
- LY-456,236
- MCPG
- NPS-2390
|
|---|
| mGluR5 |
- Agonists: ACPD
- ADX-47273
- CDPPB
- CHPG
- DFB
- DHPG
- Glutamate
- Ibotenic acid
- Quisqualic acid
- VU-1545
- Antagonists: CTEP
- DMeOB
- LY-344,545
- Mavoglurant
- MCPG
- NPS-2390
- Remeglurant
- SIB-1757
- SIB-1893; Negative allosteric modulators: Basimglurant
- Dipraglurant
- Fenobam
- GRN-529
- MPEP
- MTEP
- Raseglurant
|
|---|
|
|---|
| Group II | | mGluR2 |
- Agonists: BINA
- CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- LY-566,332
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad; Positive allosteric modulators: JNJ-40411813 (ADX-71149)
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039
- PCCG-4; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
| mGluR3 |
- Agonists: CBiPES
- DCG-IV
- Eglumegad
- Glutamate
- Ibotenic acid
- LY-379,268
- LY-404,039 (pomaglumetad)
- LY-487,379
- MGS-0028
- Pomaglumetad methionil (LY-2140023)
- Talaglumetad
- Antagonists: APICA
- CECXG
- EGLU
- HYDIA
- LY-307,452
- LY-341,495
- MCPG
- MGS-0039; Negative allosteric modulators: Decoglurant
- RO4491533
|
|---|
|
|---|
| Group III | | mGluR4 |
- Agonists: Glutamate
- L-AP4
- PHCCC
- VU-001,171
- VU-0155,041; Positive allosteric modulators: Foliglurax
- MPEP
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR6 |
- Agonists: Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR7 |
- Agonists: AMN082
- Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MMPIP
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
| mGluR8 |
- Agonists: DCPG
- Glutamate
- L-AP4
- Antagonists: CPPG
- MAP4
- MPPG
- MSOP
- MTPG
- UBP-1112
|
|---|
|
|---|
See also: Receptor/signaling modulators • Ionotropic glutamate receptor modulators • Glutamate metabolism/transport modulators |
|
 | Original source: https://en.wikipedia.org/wiki/Cytidine. Read more |